ArticleInternational journal of legal medicine2026
The potential of mRNA markers in body fluids and personal source analysis based on the QNome nanopore sequencing.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In forensic casework, unraveling the criminal nature of an event requires not only identifying the individual source of specific biological stains but also confirming their cellular origin. Recent studies have demonstrated the feasibility of identifying body fluids using specific mRNA markers and linking body fluids to their donors via coding region SNPs (cSNPs) within these mRNAs. Nanopore sequencing enables the detection of more cSNPs within longer mRNA amplicons due to its long-read capability. In this proof-of-principle study, we developed a targeted mRNA nanopore sequencing panel to simultaneously infer body fluid sources and identify individuals. This panel includes 12 body fluid-specific mRNAs and two reference genes (RGs), with a total of 41 cSNPs included in these 14 mRNA transcripts. Sequencing data showed that specific mRNAs were highly expressed in peripheral blood, semen, and menstrual blood, with an average read proportion exceeding 95% (excluding RGs reads). Cross-reactivity was observed in saliva and vaginal secretions, but all body fluid samples could still be accurately clustered. Alternative alleles were detected for 16 cSNPs, and genotyping results for randomly selected samples were validated for consistency with Sanger sequencing. The system demonstrated discriminatory power (DP) ranging from 0.5645 to 0.9017, providing information about the body fluid donor. However, further research is needed to identify more specific mRNAs, introduce additional highly polymorphic cSNPs, and perform evaluations on larger populations.
Indexed as
Identifiers
41081927What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.